| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cancer Research Center, Boston University School of Medicine, Boston, Massachusetts 02118
RING3 is a novel, nuclear-localized, serine-threonine kinase that has elevated activity in human leukemias. RING3 transforms NIH/3T3 cells and is activated by mitogenic signals, all of which suggest that it may play a role in cell cycle-responsive transcription. We tested this hypothesis with transient transfection of RING3 into fibroblasts and assayed transactivation of the promoters of cyclin D1, cyclin A, cyclin E, and dihydrofolate reductase (dhfr) genes. RING3 transactivates these promoters in a manner dependent on ras signaling. A kinase-deficient point mutant of RING3 does not transactivate. Mutational analysis of the dhfr promoter reveals that transactivation also depends on the presence of a functional E2F binding site. Furthermore, ectopic expression of Rb protein, a negative regulator of E2F activity, suppresses the RING3-dependent transactivation of this promoter. Consistent with a potential role of E2F in RING3-dependent transcription, anti-RING3 immunoaffinity chromatography or recombinant RING3 protein affinity chromatography of nuclear extracts copurified a protein complex that contains E2F-1 and E2F-2. These data suggest that RING3 is a potentially important regulator of E2F-dependent cell cycle genes.
This article has been cited by other articles:
![]() |
K. Mochizuki, A. Nishiyama, M. K. Jang, A. Dey, A. Ghosh, T. Tamura, H. Natsume, H. Yao, and K. Ozato The Bromodomain Protein Brd4 Stimulates G1 Gene Transcription and Promotes Progression to S Phase J. Biol. Chem., April 4, 2008; 283(14): 9040 - 9048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Wu and C.-M. Chiang The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation J. Biol. Chem., May 4, 2007; 282(18): 13141 - 13145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lenburg, A. Sinha, D. V. Faller, and G. V. Denis Tumor-specific and Proliferation-specific Gene Expression Typifies Murine Transgenic B Cell Lymphomagenesis J. Biol. Chem., February 16, 2007; 282(7): 4803 - 4811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Davis, K. J. Wojno, S. Daignault, M. D. Hofer, R. Kuefer, M. A. Rubin, and M. L. Day Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11897 - 11906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ottinger, T. Christalla, K. Nathan, M. M. Brinkmann, A. Viejo-Borbolla, and T. F. Schulz Kaposi's Sarcoma-Associated Herpesvirus LANA-1 Interacts with the Short Variant of BRD4 and Releases Cells from a BRD4- and BRD2/RING3-Induced G1 Cell Cycle Arrest J. Virol., November 1, 2006; 80(21): 10772 - 10786. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Wu, A-Y. Lee, S. Y. Hou, J. K. Kemper, H. Erdjument-Bromage, P. Tempst, and C.-M. Chiang Brd4 links chromatin targeting to HPV transcriptional silencing Genes & Dev., September 1, 2006; 20(17): 2383 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viejo-Borbolla, M. Ottinger, E. Bruning, A. Burger, R. Konig, E. Kati, J. A. Sheldon, and T. F. Schulz Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 J. Virol., November 1, 2005; 79(21): 13618 - 13629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Farina, M. Hattori, J. Qin, Y. Nakatani, N. Minato, and K. Ozato Bromodomain Protein Brd4 Binds to GTPase-Activating SPA-1, Modulating Its Activity and Subcellular Localization Mol. Cell. Biol., October 15, 2004; 24(20): 9059 - 9069. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Wong, G. A. Matchett, and A. C. Wilson Transcriptional Activation by the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Is Facilitated by an N-Terminal Chromatin-Binding Motif J. Virol., September 15, 2004; 78(18): 10074 - 10085. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spira, J. Beane, V. Shah, G. Liu, F. Schembri, X. Yang, J. Palma, and J. S. Brody Effects of cigarette smoke on the human airway epithelial cell transcriptome PNAS, July 6, 2004; 101(27): 10143 - 10148. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taubert, C. Gorrini, S. R. Frank, T. Parisi, M. Fuchs, H.-M. Chan, D. M. Livingston, and B. Amati E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1 Mol. Cell. Biol., May 15, 2004; 24(10): 4546 - 4556. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Greenwald, J. R. Tumang, A. Sinha, N. Currier, R. D. Cardiff, T. L. Rothstein, D. V. Faller, and G. V. Denis E{micro}-BRD2 transgenic mice develop B-cell lymphoma and leukemia Blood, February 15, 2004; 103(4): 1475 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Canaple, T. Kakizawa, and V. Laudet The Days and Nights of Cancer Cells Cancer Res., November 15, 2003; 63(22): 7545 - 7552. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dey, F. Chitsaz, A. Abbasi, T. Misteli, and K. Ozato The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis PNAS, July 22, 2003; 100(15): 8758 - 8763. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viejo-Borbolla, E. Kati, J. A. Sheldon, K. Nathan, K. Mattsson, L. Szekely, and T. F. Schulz A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear Heterochromatin J. Virol., June 15, 2003; 77(12): 7093 - 7100. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maruyama, A. Farina, A. Dey, J. Cheong, V. P. Bermudez, T. Tamura, S. Sciortino, J. Shuman, J. Hurwitz, and K. Ozato A Mammalian Bromodomain Protein, Brd4, Interacts with Replication Factor C and Inhibits Progression to S Phase Mol. Cell. Biol., September 15, 2002; 22(18): 6509 - 6520. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Crowley, E. M. Kaine, M. Yoshida, A. Nandi, and D. J. Wolgemuth Reproductive Cycle Regulation of Nuclear Import, Euchromatic Localization, and Association with Components of Pol II Mediator of a Mammalian Double-Bromodomain Protein Mol. Endocrinol., August 1, 2002; 16(8): 1727 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Houzelstein, S. L. Bullock, D. E. Lynch, E. F. Grigorieva, V. A. Wilson, and R. S. P. Beddington Growth and Early Postimplantation Defects in Mice Deficient for the Bromodomain-Containing Protein Brd4{dagger} Mol. Cell. Biol., June 1, 2002; 22(11): 3794 - 3802. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grundschober, F. Delaunay, A. Puhlhofer, G. Triqueneaux, V. Laudet, T. Bartfai, and P. Nef Circadian Regulation of Diverse Gene Products Revealed by mRNA Expression Profiling of Synchronized Fibroblasts J. Biol. Chem., December 7, 2001; 276(50): 46751 - 46758. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |